| UniProt ID | ITA5_HUMAN | |
|---|---|---|
| UniProt AC | P08648 | |
| Protein Name | Integrin alpha-5 | |
| Gene Name | ITGA5 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 1049 | |
| Subcellular Localization |
Membrane Single-pass type I membrane protein. Cell junction, focal adhesion . Cell surface . |
|
| Protein Description | Integrin alpha-5/beta-1 (ITGA5:ITGB1) is a receptor for fibronectin and fibrinogen. It recognizes the sequence R-G-D in its ligands. ITGA5:ITGB1 binds to PLA2G2A via a site (site 2) which is distinct from the classical ligand-binding site (site 1) and this induces integrin conformational changes and enhanced ligand binding to site 1. [PubMed: 18635536] | |
| Protein Sequence | MGSRTPESPLHAVQLRWGPRRRPPLLPLLLLLLPPPPRVGGFNLDAEAPAVLSGPPGSFFGFSVEFYRPGTDGVSVLVGAPKANTSQPGVLQGGAVYLCPWGASPTQCTPIEFDSKGSRLLESSLSSSEGEEPVEYKSLQWFGATVRAHGSSILACAPLYSWRTEKEPLSDPVGTCYLSTDNFTRILEYAPCRSDFSWAAGQGYCQGGFSAEFTKTGRVVLGGPGSYFWQGQILSATQEQIAESYYPEYLINLVQGQLQTRQASSIYDDSYLGYSVAVGEFSGDDTEDFVAGVPKGNLTYGYVTILNGSDIRSLYNFSGEQMASYFGYAVAATDVNGDGLDDLLVGAPLLMDRTPDGRPQEVGRVYVYLQHPAGIEPTPTLTLTGHDEFGRFGSSLTPLGDLDQDGYNDVAIGAPFGGETQQGVVFVFPGGPGGLGSKPSQVLQPLWAASHTPDFFGSALRGGRDLDGNGYPDLIVGSFGVDKAVVYRGRPIVSASASLTIFPAMFNPEERSCSLEGNPVACINLSFCLNASGKHVADSIGFTVELQLDWQKQKGGVRRALFLASRQATLTQTLLIQNGAREDCREMKIYLRNESEFRDKLSPIHIALNFSLDPQAPVDSHGLRPALHYQSKSRIEDKAQILLDCGEDNICVPDLQLEVFGEQNHVYLGDKNALNLTFHAQNVGEGGAYEAELRVTAPPEAEYSGLVRHPGNFSSLSCDYFAVNQSRLLVCDLGNPMKAGASLWGGLRFTVPHLRDTKKTIQFDFQILSKNLNNSQSDVVSFRLSVEAQAQVTLNGVSKPEAVLFPVSDWHPRDQPQKEEDLGPAVHHVYELINQGPSSISQGVLELSCPQALEGQQLLYVTRVTGLNCTTNHPINPKGLELDPEGSLHHQQKREAPSRSSASSGPQILKCPEAECFRLRCELGPLHQQESQSLQLHFRVWAKTFLQREHQPFSLQCEAVYKALKMPYRILPRQLPQKERQVATAVQWTKAEGSYGVPLWIIILAILFGLLLLGLLIYILYKLGFFKRSLPYGTAMEKAQLKPPATSDA | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 84 | N-linked_Glycosylation | LVGAPKANTSQPGVL EECCCCCCCCCCCEE | 46.52 | 22451694 | |
| 123 | Phosphorylation | KGSRLLESSLSSSEG CCCHHHHHHCCCCCC | 36.23 | 22167270 | |
| 124 | Phosphorylation | GSRLLESSLSSSEGE CCHHHHHHCCCCCCC | 23.93 | 22167270 | |
| 126 | Phosphorylation | RLLESSLSSSEGEEP HHHHHHCCCCCCCCC | 33.49 | 22167270 | |
| 127 | Phosphorylation | LLESSLSSSEGEEPV HHHHHCCCCCCCCCC | 37.39 | 22167270 | |
| 128 | Phosphorylation | LESSLSSSEGEEPVE HHHHCCCCCCCCCCE | 46.36 | 19664994 | |
| 133 | N-linked_Glycosylation | SSSEGEEPVEYKSLQ CCCCCCCCCEECEEE | 21.67 | 22451694 | |
| 137 | Ubiquitination | GEEPVEYKSLQWFGA CCCCCEECEEEEECC | 31.05 | 21906983 | |
| 164 | Phosphorylation | APLYSWRTEKEPLSD CCCCEECCCCCCCCC | 45.19 | 27251275 | |
| 166 | Ubiquitination | LYSWRTEKEPLSDPV CCEECCCCCCCCCCC | 65.11 | - | |
| 170 | Phosphorylation | RTEKEPLSDPVGTCY CCCCCCCCCCCCEEE | 51.05 | 27251275 | |
| 172 | Phosphorylation | EKEPLSDPVGTCYLS CCCCCCCCCCEEEEE | 24.06 | - | |
| 173 | Phosphorylation | KEPLSDPVGTCYLST CCCCCCCCCEEEEEC | 13.72 | - | |
| 175 | Phosphorylation | PLSDPVGTCYLSTDN CCCCCCCEEEEECCC | 9.75 | 27251275 | |
| 176 | Phosphorylation | LSDPVGTCYLSTDNF CCCCCCEEEEECCCC | 2.37 | 18578522 | |
| 177 | Phosphorylation | SDPVGTCYLSTDNFT CCCCCEEEEECCCCC | 11.97 | 19664994 | |
| 179 | Phosphorylation | PVGTCYLSTDNFTRI CCCEEEEECCCCCHH | 13.77 | 27251275 | |
| 180 | Phosphorylation | VGTCYLSTDNFTRIL CCEEEEECCCCCHHH | 32.16 | 27251275 | |
| 182 | N-linked_Glycosylation | TCYLSTDNFTRILEY EEEEECCCCCHHHHC | 40.03 | 17660510 | |
| 186 | Ubiquitination | STDNFTRILEYAPCR ECCCCCHHHHCCCCC | 2.89 | - | |
| 210 | Phosphorylation | GYCQGGFSAEFTKTG CCCCCCCEEEEEECC | 30.11 | 29507054 | |
| 215 | Ubiquitination | GFSAEFTKTGRVVLG CCEEEEEECCCEEEC | 55.06 | - | |
| 231 | N-linked_Glycosylation | PGSYFWQGQILSATQ CCCCCCCCCCCHHCH | 13.69 | 22451694 | |
| 259 | Phosphorylation | NLVQGQLQTRQASSI HHHHHHCCCCCCCCC | 27.10 | - | |
| 274 | Phosphorylation | YDDSYLGYSVAVGEF CCCCCCCEEEEEEEC | 9.44 | 22210691 | |
| 275 | Phosphorylation | DDSYLGYSVAVGEFS CCCCCCEEEEEEECC | 11.21 | 22210691 | |
| 297 | N-linked_Glycosylation | VAGVPKGNLTYGYVT CCCCCCCCEEEEEEE | 35.02 | 22451694 | |
| 304 | Phosphorylation | NLTYGYVTILNGSDI CEEEEEEEEECCCHH | 15.97 | 22210691 | |
| 307 | N-linked_Glycosylation | YGYVTILNGSDIRSL EEEEEEECCCHHHHH | 44.03 | 22451694 | |
| 309 | Phosphorylation | YVTILNGSDIRSLYN EEEEECCCHHHHHCC | 28.88 | 22210691 | |
| 316 | N-linked_Glycosylation | SDIRSLYNFSGEQMA CHHHHHCCCCHHHHH | 29.87 | 22451694 | |
| 346 | N-linked_Glycosylation | GLDDLLVGAPLLMDR CHHHHCCCCCEEEEC | 22.80 | 19349973 | |
| 346 | N-linked_Glycosylation | GLDDLLVGAPLLMDR CHHHHCCCCCEEEEC | 22.80 | 19349973 | |
| 354 | Phosphorylation | APLLMDRTPDGRPQE CCEEEECCCCCCCCC | 22.82 | 29052541 | |
| 356 | N-linked_Glycosylation | LLMDRTPDGRPQEVG EEEECCCCCCCCCCC | 66.18 | 19349973 | |
| 356 | N-linked_Glycosylation | LLMDRTPDGRPQEVG EEEECCCCCCCCCCC | 66.18 | 19349973 | |
| 365 | N-linked_Glycosylation | RPQEVGRVYVYLQHP CCCCCCEEEEEEECC | 2.89 | 22451694 | |
| 394 | Phosphorylation | DEFGRFGSSLTPLGD CCCCCCCCCCCCCCC | 21.33 | - | |
| 395 | Phosphorylation | EFGRFGSSLTPLGDL CCCCCCCCCCCCCCC | 36.32 | - | |
| 471 | Phosphorylation | RDLDGNGYPDLIVGS CCCCCCCCCCEEEEE | 9.51 | 26699800 | |
| 478 | Phosphorylation | YPDLIVGSFGVDKAV CCCEEEEEECCCEEE | 14.13 | 26699800 | |
| 487 | Phosphorylation | GVDKAVVYRGRPIVS CCCEEEEECCCCEEE | 10.76 | - | |
| 524 | N-linked_Glycosylation | GNPVACINLSFCLNA CCCEEEEEEEEEECC | 29.53 | UniProtKB CARBOHYD | |
| 530 | N-linked_Glycosylation | INLSFCLNASGKHVA EEEEEEECCCCCCCH | 32.99 | UniProtKB CARBOHYD | |
| 593 | N-linked_Glycosylation | EMKIYLRNESEFRDK HCEEEECCHHHHHHH | 55.33 | UniProtKB CARBOHYD | |
| 609 | N-linked_Glycosylation | SPIHIALNFSLDPQA CCEEEEEECCCCCCC | 18.55 | 22451694 | |
| 658 | N-linked_Glycosylation | CVPDLQLEVFGEQNH ECCCEEEEEECCCCE | 23.88 | 22451694 | |
| 672 | N-linked_Glycosylation | HVYLGDKNALNLTFH EEEECCCCEEEEEEE | 55.17 | - | |
| 675 | N-linked_Glycosylation | LGDKNALNLTFHAQN ECCCCEEEEEEEEEE | 34.32 | 19159218 | |
| 682 | N-linked_Glycosylation | NLTFHAQNVGEGGAY EEEEEEEECCCCCEE | 44.54 | 19349973 | |
| 712 | N-linked_Glycosylation | GLVRHPGNFSSLSCD CCCCCCCCCCCCCCC | 37.77 | 17660510 | |
| 721 | N-linked_Glycosylation | SSLSCDYFAVNQSRL CCCCCCEEEECCCEE | 3.80 | 19349973 | |
| 724 | N-linked_Glycosylation | SCDYFAVNQSRLLVC CCCEEEECCCEEEEE | 30.58 | 17660510 | |
| 724 | N-linked_Glycosylation | SCDYFAVNQSRLLVC CCCEEEECCCEEEEE | 30.58 | 19349973 | |
| 731 | N-linked_Glycosylation | NQSRLLVCDLGNPMK CCCEEEEEECCCCCC | 3.45 | 19349973 | |
| 731 | S-nitrosylation | NQSRLLVCDLGNPMK CCCEEEEEECCCCCC | 3.45 | 25040305 | |
| 742 | Phosphorylation | NPMKAGASLWGGLRF CCCCCCCHHCCCEEE | 24.60 | 21406692 | |
| 760 | Phosphorylation | HLRDTKKTIQFDFQI CCCCCCCEEEEEHHH | 22.90 | 21406692 | |
| 769 | Phosphorylation | QFDFQILSKNLNNSQ EEEHHHHHHCCCCCC | 22.56 | 24719451 | |
| 771 | N-linked_Glycosylation | DFQILSKNLNNSQSD EHHHHHHCCCCCCCC | 44.62 | 19349973 | |
| 773 | N-linked_Glycosylation | QILSKNLNNSQSDVV HHHHHCCCCCCCCEE | 56.34 | 17660510 | |
| 774 | N-linked_Glycosylation | ILSKNLNNSQSDVVS HHHHCCCCCCCCEEE | 44.59 | 19349973 | |
| 791 | Phosphorylation | LSVEAQAQVTLNGVS EEEEEEEEEEECCCC | 19.35 | - | |
| 820 | N-linked_Glycosylation | RDQPQKEEDLGPAVH CCCCCCHHHCHHHHH | 66.62 | 19349973 | |
| 822 | N-linked_Glycosylation | QPQKEEDLGPAVHHV CCCCHHHCHHHHHHH | 11.36 | 19349973 | |
| 822 | N-linked_Glycosylation | QPQKEEDLGPAVHHV CCCCHHHCHHHHHHH | 11.36 | 19349973 | |
| 823 | N-linked_Glycosylation | PQKEEDLGPAVHHVY CCCHHHCHHHHHHHH | 22.05 | 19349973 | |
| 868 | N-linked_Glycosylation | VTRVTGLNCTTNHPI EEEECCCCCCCCCCC | 23.57 | UniProtKB CARBOHYD | |
| 887 | Phosphorylation | LELDPEGSLHHQQKR CEECCCCCCCCCCCC | 23.91 | - | |
| 901 | O-linked_Glycosylation | REAPSRSSASSGPQI CCCCCCCCCCCCCCE | 30.93 | OGP | |
| 943 | Ubiquitination | LHFRVWAKTFLQREH HHHHHHHHHHHHHCC | 24.89 | - | |
| 992 | Ubiquitination | AVQWTKAEGSYGVPL HHHHHHCCCCCHHHH | 50.67 | - | |
| 1038 | Ubiquitination | PYGTAMEKAQLKPPA CCCCHHHHCCCCCCC | 28.48 | - | |
| 1042 | Ubiquitination | AMEKAQLKPPATSDA HHHHCCCCCCCCCCC | 36.55 | 21906983 | |
| 1046 | Phosphorylation | AQLKPPATSDA---- CCCCCCCCCCC---- | 32.67 | 23403867 | |
| 1047 | Phosphorylation | QLKPPATSDA----- CCCCCCCCCC----- | 33.38 | 23403867 | |
| 1091 | Ubiquitination | ------------------------------------------------- ------------------------------------------------- | - | ||
| 1096 | Phosphorylation | ------------------------------------------------------ ------------------------------------------------------ | - |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ITA5_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ITA5_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| ILK_HUMAN | ILK | physical | 8538749 | |
| CD9_HUMAN | CD9 | physical | 10065872 | |
| GIPC1_HUMAN | GIPC1 | physical | 11479315 | |
| MSS4_HUMAN | RABIF | physical | 10094488 | |
| FGFR2_HUMAN | FGFR2 | physical | 15728256 | |
| UBC_HUMAN | UBC | physical | 15728256 | |
| FINC_HUMAN | FN1 | physical | 20643357 | |
| ITB1_HUMAN | ITGB1 | physical | 20643357 | |
| SHRPN_HUMAN | SHARPIN | physical | 21947080 | |
| ITB1_HUMAN | ITGB1 | physical | 21947080 | |
| ITB1_HUMAN | ITGB1 | physical | 22939629 | |
| STABP_HUMAN | STAMBP | physical | 21988832 | |
| SE1L1_HUMAN | SEL1L | physical | 24324549 | |
| ITB1_HUMAN | ITGB1 | physical | 26344197 | |
| ITB3_HUMAN | ITGB3 | physical | 26344197 | |
| LG3BP_HUMAN | LGALS3BP | physical | 24362527 | |
| ITB3_HUMAN | ITGB3 | physical | 10358085 | |
| CIB1_HUMAN | CIB1 | physical | 24163826 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| D06319 | Volociximab (USAN) | |||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| N-linked Glycosylation | |
| Reference | PubMed |
| "Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins."; Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M.,Schiess R., Aebersold R., Watts J.D.; Nat. Biotechnol. 27:378-386(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-297; ASN-307; ASN-771 ANDASN-773, AND MASS SPECTROMETRY. | |
| "Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry."; Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.; J. Proteome Res. 8:651-661(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-297; ASN-307; ASN-675 ANDASN-773, AND MASS SPECTROMETRY. | |